Table 1.
Differences in demographic, clinical, and MRI findings among visual outcome groups
| Group 1 | Group 2 | Group 2 | |||
|---|---|---|---|---|---|
| N | No Vision Loss (N=28) |
Some Vision Loss (N=10) |
Severe Vision Loss (N=8) |
P | |
| Demographic and Clinical Findings | |||||
| Age (Years) | 46 | 31.8 (26.2–39.7) | 30.6 (27.8–43.7) | 21.5 (20.1–27.4) | 0.03 |
| Gender (Male) | 46 | 11% (3) | 0% (0) | 12% (1) | 0.61 |
| Race (Non-Black) | 46 | 57% (16) | 30% (3) | 38% (3) | 0.32 |
| Body Mass Index | 44 | 39.4 (34.9–42.7) | 37.9 (34.4–41.0) | 33.3 (30.4–39.0) | 0.45 |
| OP (cm H2O) | 46 | 31.0 (29.0–37.3) | 31.4 (28.3–36.9) | 48.5 (39.5–55.3) | 0.04 |
| Frequency of Orbital Findings on MRI | |||||
| ON Head Protrusion | 46 | 57% (16) | 70% (7) | 50% (4) | 0.77 |
| ON Head Enhancement | 42 | 28% (7) | 10% (1) | 43% (3) | 0.33 |
| Scleral Flattening | 46 | 82% (23) | 80% (8) | 100% (8) | 0.61 |
| Increased Perioptic CSF | 46 | 89% (25) | 80% (8) | 100% (8) | 0.54 |
| ON Tortuosity | 46 | 57% (16) | 70% (7) | 50% (4) | 0.77 |
| Osseous and Venous Findings on MRI | |||||
| Pituitary Grade | |||||
| 1 | 46 | 4% (1) | 0% (0) | 12% (1) | 0.29 |
| 2 | 11% (3) | 20% (2) | 12% (1) | ||
| 3 | 32% (9) | 10% (1) | 38% (3) | ||
| 4 | 46% (13) | 50% (5) | 38% (3) | ||
| 5 | 7% (2) | 20% (2) | 0% (0) | ||
| Optic Canal Width (mm) | 46 | 4.0 (3.7–4.1) | 3.6 (3.5–4.0) | 3.9 (3.7–4.0) | 0.27 |
| Cephaloceles | 46 | 21% (6) | 50% (5) | 0% (0) | 0.04 |
| TSS on MRV | 46 | 96% (27) | 90% (9) | 100% (8) | 0.64 |
Continuous data are listed as median (25th percentile–75th percentile). Categorical data are listed as percentage (frequency). Data analysis assessed associations with the Fisher exact test for categorical data and the Spearman correlation for data with continuous outcomes.